MX389665B - Procesos para producir fenilacetato de l-ornitina - Google Patents
Procesos para producir fenilacetato de l-ornitinaInfo
- Publication number
- MX389665B MX389665B MX2019013325A MX2019013325A MX389665B MX 389665 B MX389665 B MX 389665B MX 2019013325 A MX2019013325 A MX 2019013325A MX 2019013325 A MX2019013325 A MX 2019013325A MX 389665 B MX389665 B MX 389665B
- Authority
- MX
- Mexico
- Prior art keywords
- processes
- ornithine phenylacetate
- producing
- ornithine
- phenylacetate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
- C07C227/42—Crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/32—Phenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762504911P | 2017-05-11 | 2017-05-11 | |
| PCT/US2018/031405 WO2018208677A1 (en) | 2017-05-11 | 2018-05-07 | Processes of making l-ornithine phenylacetate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX389665B true MX389665B (es) | 2025-03-20 |
Family
ID=64104920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019013325A MX389665B (es) | 2017-05-11 | 2018-05-07 | Procesos para producir fenilacetato de l-ornitina |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11066352B2 (https=) |
| EP (1) | EP3621947A4 (https=) |
| JP (1) | JP7126520B2 (https=) |
| KR (1) | KR20200024145A (https=) |
| CN (1) | CN110740988A (https=) |
| AU (1) | AU2018266357B2 (https=) |
| CA (1) | CA3063134A1 (https=) |
| IL (1) | IL270413B (https=) |
| MX (1) | MX389665B (https=) |
| WO (1) | WO2018208677A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2757373C (en) | 2009-04-03 | 2018-05-08 | Ocera Therapeutics, Inc. | L-ornithine phenyl acetate and methods of making thereof |
| KR102852068B1 (ko) * | 2019-05-09 | 2025-08-28 | 오세라 테라퓨틱스, 아이엔씨. | 간성 뇌증의 평가 및 치료 방법 |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB965637A (en) | 1962-04-23 | 1964-08-06 | Tanabe Seiyaku Co | L-ornithine l-aspartate |
| NL302572A (https=) | 1962-12-27 | |||
| GB1067742A (en) | 1963-09-16 | 1967-05-03 | Kyowa Hakko Kogyo Kk | Process for the preparation of l-ornithine l-aspartate |
| ZA716628B (en) | 1970-10-15 | 1972-06-28 | Richardson Merrell Spa | Composition and method for treatment of hepatic disease and mental fatigue |
| FR2113774A1 (en) | 1970-11-13 | 1972-06-30 | Roques Ets | Prepn of l-ornithine salts with org acids - using silver oxides |
| US4100293A (en) | 1974-04-15 | 1978-07-11 | The Johns Hopkins University | Treatment of hepatic disorders with therapeutic compositions comprising keto analogs of essential amino acids |
| US3950529A (en) | 1975-02-03 | 1976-04-13 | Massachusetts General Hospital | Amino acid formulations for patients with liver disease and method of using same |
| US4228099A (en) | 1978-03-17 | 1980-10-14 | The Johns Hopkins University | Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders |
| US4320146A (en) | 1978-03-17 | 1982-03-16 | The Johns Hopkins University | Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids |
| US4352814A (en) | 1979-04-18 | 1982-10-05 | The Johns Hopkins University | Treatment of hepatic and renal disorders with mixed salts of essential or semi-essential amino acids and nitrogen-free analogs |
| US4284647A (en) | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| US4457942A (en) | 1982-08-20 | 1984-07-03 | Brusilow Saul W | Process for waste nitrogen removal |
| US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
| US5139981A (en) | 1987-06-24 | 1992-08-18 | Union Carbide Chemicals & Plastics Technology Corporation | Process for preparing silver(I)-exchanged resins |
| DE4020980C1 (https=) | 1990-07-02 | 1991-09-26 | Degussa Ag, 6000 Frankfurt, De | |
| US5591613A (en) | 1990-07-02 | 1997-01-07 | Degussa Aktiengesellschaft | Method for the preparation of D-arginine and L-ornithine |
| JP3127484B2 (ja) | 1991-02-28 | 2001-01-22 | 味の素株式会社 | 肝炎治療薬 |
| US5767086A (en) | 1992-04-03 | 1998-06-16 | Terrapin Technologies, Inc. | Bone marrow stimulation by certain glutathione analogs |
| US5571783A (en) | 1993-03-09 | 1996-11-05 | Clintec Nutrition Company | Composition and method for treating patients with hepatic disease |
| JP3273578B2 (ja) | 1993-09-21 | 2002-04-08 | 第一化学薬品株式会社 | オルニチンと酸性アミノ酸類又はケト酸類との塩の製造法 |
| US5840891A (en) | 1994-07-28 | 1998-11-24 | Syntex (U.S.A.) Inc. | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative |
| IL116674A (en) | 1995-01-09 | 2003-05-29 | Mendell Co Inc Edward | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof |
| AU2251897A (en) | 1996-02-13 | 1997-09-02 | Trustees Of The University Of Pennsylvania, The | Method of treating liver disorders |
| ZA986614B (en) | 1997-07-25 | 1999-01-27 | Gilead Sciences | Nucleotide analog composition |
| GB9815567D0 (en) | 1998-07-18 | 1998-09-16 | Glaxo Group Ltd | Antiviral compound |
| US6258849B1 (en) | 1998-07-23 | 2001-07-10 | Stanislaw R. Burzynski | Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| EP1179347A4 (en) | 1999-05-21 | 2002-06-26 | Takeda Chemical Industries Ltd | CONTROL SUBSTANCES FOR LIVER FUNCTION |
| US6768024B1 (en) | 2000-08-04 | 2004-07-27 | Lion Bioscience Ag | Triamine derivative melanocortin receptor ligands and methods of using same |
| JP3211824B1 (ja) | 2000-10-26 | 2001-09-25 | 味の素株式会社 | 分岐鎖アミノ酸含有医薬用顆粒製剤とその製造方法 |
| ATE441409T1 (de) | 2001-03-15 | 2009-09-15 | Riken | Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber |
| US6503530B1 (en) | 2001-11-01 | 2003-01-07 | Chunghee Kimberly Kang | Method of preventing development of severe metabolic derangement in inborn errors of metabolism |
| US20030105104A1 (en) | 2001-11-27 | 2003-06-05 | Burzynski Stanislaw R. | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| US20040229948A1 (en) | 2002-04-12 | 2004-11-18 | Summar Marshall L. | Method for preventing hepatic encephalopathic episodes |
| US20030195255A1 (en) | 2002-04-12 | 2003-10-16 | Summar Marshall L. | Method for treating hepatic encephalopathies |
| CN1383815A (zh) | 2002-05-08 | 2002-12-11 | 刘万忠 | 防治肝病、肝性脑病的鸟氨酸和门冬氨酸的复方制剂及其制备方法 |
| US20040152784A1 (en) | 2002-07-23 | 2004-08-05 | Special Products Limited | Pharmaceutical composition and method for treatment of a urea cycle deficiency or sickle-cell anaemia |
| WO2004019928A1 (ja) | 2002-08-30 | 2004-03-11 | Ajinomoto Co., Inc. | 肝疾患治療剤 |
| US20050059150A1 (en) | 2003-09-17 | 2005-03-17 | Becton, Dickinson And Company | Environments that maintain function of primary liver cells |
| MXPA03009902A (es) * | 2003-10-29 | 2005-05-03 | Manuel Francisco Lara Och Jose | Compuestos para reducir la hiperamonemia en pacientes con cirrosis u otras incapacidad para la eliminacion de amonio. |
| EP1718667B1 (en) | 2004-02-23 | 2013-01-09 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| EP1744770A2 (en) | 2004-05-06 | 2007-01-24 | Osteologix A/S | High yield and rapid syntheses methods for producing metallo-organic salts |
| CA2582255A1 (en) | 2004-08-30 | 2006-08-08 | Lunamed, Inc. | 4-phenylbutyric acid controlled-release formulations for therapeutic use |
| SG158073A1 (en) | 2004-11-26 | 2010-01-29 | Ucl Business Plc | Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| CA2757373C (en) | 2009-04-03 | 2018-05-08 | Ocera Therapeutics, Inc. | L-ornithine phenyl acetate and methods of making thereof |
| AU2015221466B2 (en) * | 2009-04-03 | 2017-02-02 | Ocera Therapeutics, Inc. | L-ornithine phenyl acetate and methods of making thereof |
| CA2763894A1 (en) | 2009-06-02 | 2011-01-13 | Salix Pharmaceuticals, Ltd. | Use of rifaximin to maintain remission of hepatic encephalopathy |
| AU2014250643B2 (en) | 2009-06-08 | 2016-07-14 | Ocera Therapeutics, Inc. | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate |
| EA201691430A1 (ru) | 2009-06-08 | 2017-02-28 | ЮСиЭл БИЗНЕС ПиЭлСи | Лечение портальной гипертензии и восстановление функции печени с помощью l-орнитинфенилацетата |
| MX360062B (es) * | 2010-10-06 | 2018-10-22 | Ocera Therapeutics Inc | Metodos de elaboracion de fenilacetato de l-ornitina. |
| CN102993037B (zh) | 2012-11-20 | 2015-03-04 | 南京工业大学 | 一种l-鸟氨酸苯乙酸盐的制备方法 |
| EP2922576B1 (en) | 2012-11-21 | 2017-11-08 | Horizon Therapeutics, LLC | Methods of administering and evaluating nitrogen scavenging drugs for the treatment of hepatic encephalopathy |
| US10039735B2 (en) | 2014-11-24 | 2018-08-07 | Ucl Business Plc | Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies |
| RU2755904C2 (ru) | 2015-04-20 | 2021-09-22 | Осера Терапьютикс, Инк. | Составы l-орнитин фенилацетата |
| EP3337473A4 (en) | 2015-08-18 | 2019-04-17 | Ocera Therapeutics, Inc. | TREATMENT AND PREVENTION OF MUSCLE WOUND BY L-ORNITHIN IN COMBINATION WITH AT LEAST ONE PHENYL ACETATE AND PHENYL BUTYRATE |
| US11219611B2 (en) | 2015-11-13 | 2022-01-11 | Ocera Therapeutics, Inc. | Formulations of L-ornithine phenylacetate |
-
2018
- 2018-05-07 WO PCT/US2018/031405 patent/WO2018208677A1/en not_active Ceased
- 2018-05-07 CA CA3063134A patent/CA3063134A1/en active Pending
- 2018-05-07 IL IL270413A patent/IL270413B/en unknown
- 2018-05-07 AU AU2018266357A patent/AU2018266357B2/en active Active
- 2018-05-07 KR KR1020197036485A patent/KR20200024145A/ko not_active Ceased
- 2018-05-07 CN CN201880030339.2A patent/CN110740988A/zh active Pending
- 2018-05-07 MX MX2019013325A patent/MX389665B/es unknown
- 2018-05-07 US US16/611,193 patent/US11066352B2/en active Active
- 2018-05-07 EP EP18798440.6A patent/EP3621947A4/en not_active Withdrawn
- 2018-05-07 JP JP2019561997A patent/JP7126520B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20200157033A1 (en) | 2020-05-21 |
| EP3621947A4 (en) | 2021-03-10 |
| EP3621947A1 (en) | 2020-03-18 |
| AU2018266357B2 (en) | 2022-12-08 |
| US11066352B2 (en) | 2021-07-20 |
| KR20200024145A (ko) | 2020-03-06 |
| WO2018208677A1 (en) | 2018-11-15 |
| CA3063134A1 (en) | 2018-11-15 |
| IL270413B (en) | 2022-08-01 |
| AU2018266357A1 (en) | 2019-11-14 |
| CN110740988A (zh) | 2020-01-31 |
| JP2020519624A (ja) | 2020-07-02 |
| IL270413A (https=) | 2020-01-30 |
| JP7126520B2 (ja) | 2022-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20180525A (es) | Producción de ácido ribonucleico libre de células | |
| CL2017002427A1 (es) | Producción de ácido ribonucleico libre de células. | |
| MX360062B (es) | Metodos de elaboracion de fenilacetato de l-ornitina. | |
| BR112017004231A2 (pt) | processo para produzir um precipitado estável enriquecido em ficobiliproteínas | |
| MX2016003892A (es) | Uso de dihidrooxindolilsulfonamidas sustituidas, o sus sales, para aumentar la tolerancia de plantas al estres. | |
| MX395699B (es) | Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas. | |
| EA201691424A1 (ru) | Применение гуанидинуксусной кислоты и/или креатина для повышения показателя вывода цыплят | |
| MX2017006200A (es) | Procesos e intermediarios para preparar dialcano eteres terminados con acido a, ?-dicarboxilico. | |
| PH12016500913A1 (en) | Soap bar | |
| MX389665B (es) | Procesos para producir fenilacetato de l-ornitina | |
| MX385406B (es) | Formulación de biomasa. | |
| MX384260B (es) | Proceso para la preparacion de 3,7-dimetilnonan-1-ol. | |
| BR112022002909A2 (pt) | Suspensões concentradas de metribuzin e diflufenicam altamente concentradas e sem cristalização | |
| BR112015028677A2 (pt) | corantes ácidos, processo para a produção dos mesmos e seus usos | |
| CL2016000498A1 (es) | Proceso para la producción de lactato. | |
| MX2016005222A (es) | Tinturas acidas, proceso para su produccion y su uso. | |
| UY35347A (es) | Formas cristalinas de un inhibidor de la prolil hidroxilasa | |
| TH60150S1 (th) | กำไล | |
| TH60476S1 (th) | กำไล | |
| TH165395S (th) | กำไล | |
| TH168160S (th) | ชิ้นส่วนเครื่องประดับ | |
| TH63842S1 (th) | ชิ้นส่วนเครื่องประดับ | |
| TH159177S (th) | กำไล | |
| TH152225B (th) | นาฬิกาข้อมือ | |
| TH51023S1 (th) | หน้าตัดโลหะ |